Methylated Cytochrome P450 and the Solute Carrier Family of Genes Correlate With Perturbations in Bile Acid Metabolism in Parkinson’s Disease
Parkinson’s disease (PD) is second most prevalent neurodegenerative disorder following Alzheimer’s disease. Parkinson’s disease is hypothesized to be caused by a multifaceted interplay between genetic and environmental factors. Herein, and for the first time, we describe the integration of metabolom...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2022.804261/full |
_version_ | 1818307961316966400 |
---|---|
author | Sangeetha Vishweswaraiah Sumeyya Akyol Ali Yilmaz Zafer Ugur Juozas Gordevičius Kyung Joon Oh Patrik Brundin Uppala Radhakrishna Viviane Labrie Stewart F. Graham |
author_facet | Sangeetha Vishweswaraiah Sumeyya Akyol Ali Yilmaz Zafer Ugur Juozas Gordevičius Kyung Joon Oh Patrik Brundin Uppala Radhakrishna Viviane Labrie Stewart F. Graham |
author_sort | Sangeetha Vishweswaraiah |
collection | DOAJ |
description | Parkinson’s disease (PD) is second most prevalent neurodegenerative disorder following Alzheimer’s disease. Parkinson’s disease is hypothesized to be caused by a multifaceted interplay between genetic and environmental factors. Herein, and for the first time, we describe the integration of metabolomics and epigenetics (genome-wide DNA methylation; epimetabolomics) to profile the frontal lobe from people who died from PD and compared them with age-, and sex-matched controls. We identified 48 metabolites to be at significantly different concentrations (FDR q < 0.05), 4,313 differentially methylated sites [5’-C-phosphate-G-3’ (CpGs)] (FDR q < 0.05) and increased DNA methylation age in the primary motor cortex of people who died from PD. We identified Primary bile acid biosynthesis as the major biochemical pathway to be perturbed in the frontal lobe of PD sufferers, and the metabolite taurine (p-value = 5.91E-06) as being positively correlated with CpG cg14286187 (SLC25A27; CYP39A1) (FDR q = 0.002), highlighting previously unreported biochemical changes associated with PD pathogenesis. In this novel multi-omics study, we identify regulatory mechanisms which we believe warrant future translational investigation and central biomarkers of PD which require further validation in more accessible biomatrices. |
first_indexed | 2024-12-13T07:06:42Z |
format | Article |
id | doaj.art-4e5cb75fdff04f49bba0fcfc9dbc0b47 |
institution | Directory Open Access Journal |
issn | 1662-453X |
language | English |
last_indexed | 2024-12-13T07:06:42Z |
publishDate | 2022-03-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Neuroscience |
spelling | doaj.art-4e5cb75fdff04f49bba0fcfc9dbc0b472022-12-21T23:55:47ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2022-03-011610.3389/fnins.2022.804261804261Methylated Cytochrome P450 and the Solute Carrier Family of Genes Correlate With Perturbations in Bile Acid Metabolism in Parkinson’s DiseaseSangeetha Vishweswaraiah0Sumeyya Akyol1Ali Yilmaz2Zafer Ugur3Juozas Gordevičius4Kyung Joon Oh5Patrik Brundin6Uppala Radhakrishna7Viviane Labrie8Stewart F. Graham9Beaumont Health, Royal Oak, MI, United StatesBeaumont Health, Royal Oak, MI, United StatesBeaumont Health, Royal Oak, MI, United StatesBeaumont Health, Royal Oak, MI, United StatesVan Andel Institute, Grand Rapids, MI, United StatesBeaumont Health, Royal Oak, MI, United StatesVan Andel Institute, Grand Rapids, MI, United StatesBeaumont Health, Royal Oak, MI, United StatesVan Andel Institute, Grand Rapids, MI, United StatesBeaumont Health, Royal Oak, MI, United StatesParkinson’s disease (PD) is second most prevalent neurodegenerative disorder following Alzheimer’s disease. Parkinson’s disease is hypothesized to be caused by a multifaceted interplay between genetic and environmental factors. Herein, and for the first time, we describe the integration of metabolomics and epigenetics (genome-wide DNA methylation; epimetabolomics) to profile the frontal lobe from people who died from PD and compared them with age-, and sex-matched controls. We identified 48 metabolites to be at significantly different concentrations (FDR q < 0.05), 4,313 differentially methylated sites [5’-C-phosphate-G-3’ (CpGs)] (FDR q < 0.05) and increased DNA methylation age in the primary motor cortex of people who died from PD. We identified Primary bile acid biosynthesis as the major biochemical pathway to be perturbed in the frontal lobe of PD sufferers, and the metabolite taurine (p-value = 5.91E-06) as being positively correlated with CpG cg14286187 (SLC25A27; CYP39A1) (FDR q = 0.002), highlighting previously unreported biochemical changes associated with PD pathogenesis. In this novel multi-omics study, we identify regulatory mechanisms which we believe warrant future translational investigation and central biomarkers of PD which require further validation in more accessible biomatrices.https://www.frontiersin.org/articles/10.3389/fnins.2022.804261/fullmetabolomicsepigeneticsintegrative omicsepimetabolomicsParkinson’s diseaseetiopathophysiology |
spellingShingle | Sangeetha Vishweswaraiah Sumeyya Akyol Ali Yilmaz Zafer Ugur Juozas Gordevičius Kyung Joon Oh Patrik Brundin Uppala Radhakrishna Viviane Labrie Stewart F. Graham Methylated Cytochrome P450 and the Solute Carrier Family of Genes Correlate With Perturbations in Bile Acid Metabolism in Parkinson’s Disease Frontiers in Neuroscience metabolomics epigenetics integrative omics epimetabolomics Parkinson’s disease etiopathophysiology |
title | Methylated Cytochrome P450 and the Solute Carrier Family of Genes Correlate With Perturbations in Bile Acid Metabolism in Parkinson’s Disease |
title_full | Methylated Cytochrome P450 and the Solute Carrier Family of Genes Correlate With Perturbations in Bile Acid Metabolism in Parkinson’s Disease |
title_fullStr | Methylated Cytochrome P450 and the Solute Carrier Family of Genes Correlate With Perturbations in Bile Acid Metabolism in Parkinson’s Disease |
title_full_unstemmed | Methylated Cytochrome P450 and the Solute Carrier Family of Genes Correlate With Perturbations in Bile Acid Metabolism in Parkinson’s Disease |
title_short | Methylated Cytochrome P450 and the Solute Carrier Family of Genes Correlate With Perturbations in Bile Acid Metabolism in Parkinson’s Disease |
title_sort | methylated cytochrome p450 and the solute carrier family of genes correlate with perturbations in bile acid metabolism in parkinson s disease |
topic | metabolomics epigenetics integrative omics epimetabolomics Parkinson’s disease etiopathophysiology |
url | https://www.frontiersin.org/articles/10.3389/fnins.2022.804261/full |
work_keys_str_mv | AT sangeethavishweswaraiah methylatedcytochromep450andthesolutecarrierfamilyofgenescorrelatewithperturbationsinbileacidmetabolisminparkinsonsdisease AT sumeyyaakyol methylatedcytochromep450andthesolutecarrierfamilyofgenescorrelatewithperturbationsinbileacidmetabolisminparkinsonsdisease AT aliyilmaz methylatedcytochromep450andthesolutecarrierfamilyofgenescorrelatewithperturbationsinbileacidmetabolisminparkinsonsdisease AT zaferugur methylatedcytochromep450andthesolutecarrierfamilyofgenescorrelatewithperturbationsinbileacidmetabolisminparkinsonsdisease AT juozasgordevicius methylatedcytochromep450andthesolutecarrierfamilyofgenescorrelatewithperturbationsinbileacidmetabolisminparkinsonsdisease AT kyungjoonoh methylatedcytochromep450andthesolutecarrierfamilyofgenescorrelatewithperturbationsinbileacidmetabolisminparkinsonsdisease AT patrikbrundin methylatedcytochromep450andthesolutecarrierfamilyofgenescorrelatewithperturbationsinbileacidmetabolisminparkinsonsdisease AT uppalaradhakrishna methylatedcytochromep450andthesolutecarrierfamilyofgenescorrelatewithperturbationsinbileacidmetabolisminparkinsonsdisease AT vivianelabrie methylatedcytochromep450andthesolutecarrierfamilyofgenescorrelatewithperturbationsinbileacidmetabolisminparkinsonsdisease AT stewartfgraham methylatedcytochromep450andthesolutecarrierfamilyofgenescorrelatewithperturbationsinbileacidmetabolisminparkinsonsdisease |